Steba: companies and medicines worldwide

Loading your page…

Sources and licences

Medicine	Substance	Country	Status	Authorised
Tookad	Padeliporfin	EU (EMA)	Authorised	2017
TOOKADPolvere per soluzione iniettabile	Padeliporfin	Italy	Authorised
TOOKAD 183 MG POLVO PARA SOLUCION INYECTABLE183 mg · Polvo para solución inyectable	Padeliporfin	Spain	Authorised	2019
Tookad 200 mg poeder voor oplossing voor injectiePoeder voor oplossing voor injectie	Padeliporfin	Netherlands	Authorised	2017
TOOKAD 366 MG POLVO PARA SOLUCION INYECTABLE366 mg · Polvo para solución inyectable	Padeliporfin	Spain	Authorised	2019
Tookad 400 mg poeder voor oplossing voor injectiePoeder voor oplossing voor injectie	Padeliporfin	Netherlands	Authorised	2017

Medicine	Substance	Country	Status	Authorised
Tookad	Padeliporfin	EU (EMA)	Authorised	2017
TOOKADPolvere per soluzione iniettabile	Padeliporfin	Italy	Authorised
TOOKAD 183 MG POLVO PARA SOLUCION INYECTABLE183 mg · Polvo para solución inyectable	Padeliporfin	Spain	Authorised	2019
Tookad 200 mg poeder voor oplossing voor injectiePoeder voor oplossing voor injectie	Padeliporfin	Netherlands	Authorised	2017
TOOKAD 366 MG POLVO PARA SOLUCION INYECTABLE366 mg · Polvo para solución inyectable	Padeliporfin	Spain	Authorised	2019
Tookad 400 mg poeder voor oplossing voor injectiePoeder voor oplossing voor injectie	Padeliporfin	Netherlands	Authorised	2017

Country	Medicines	Current	Companies
Spain	2	2	Companies All medicines
Netherlands	2	2	Companies All medicines
European Union (EMA)	1	1	Companies All medicines
Italy	1	1	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

All 9 sources

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Report an error or request removalCorrections from the company itself are welcome.

Steba

Group structure

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Steba

Group structure

Headquarters not stated2

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups